Although further investigation is required to clarify the direct regulatory relationship between MED12 and MYC, our results suggest that functional loss of MED12 attenuates AKT-mediated survival signaling, thereby increasing the vulnerability of cancer cells to MEK inhibition. This evidence concerns the gene AKT1 and cancer.